Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer

NCT07229339 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Lung Non-Squamous Non-Small Cell Carcinoma

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Carboplatin
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Pemetrexed
PROCEDURE: Positron Emission Tomography
DRUG: Zipalertinib

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]